CF
CVS icon

Copperwynd Financial’s CVS Health CVS Stock Holding History

Copperwynd Financial’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$850K Sell
12,316
-55
-0.4% -$3.61K 0.21% 88
2025
Q1 		$838K Buy
12,371
+7,734
+167% +$463K 0.23% 88
2024
Q4 		$208K Sell
4,637
-4,856
-51% -$272K 0.06% 131
2024
Q3 		$597K Sell
9,493
-175
-2% -$10.2K 0.18% 101
2024
Q2 		$583K Sell
9,668
-8,028
-45% -$502K 0.19% 99
2024
Q1 		$1.41M Sell
17,696
-621
-3% -$47.4K 0.51% 36
2023
Q4 		$1.45M Buy
18,317
+3,034
+20% +$216K 0.58% 30
2023
Q3 		$1.07M Buy
15,283
+177
+1% +$12.5K 0.5% 34
2023
Q2 		$1.04M Buy
15,106
+3,139
+26% +$223K 0.49% 43
2023
Q1 		$889K Buy
11,967
+143
+1% +$12K 0.45% 46
2022
Q4 		$1.1M Sell
11,824
-13,064
-52% -$1.26M 0.62% 41
2022
Q3 		$2.37M Sell
24,888
-389
-2% -$38.5K 1.37% 14
2022
Q2 		$2.34M Buy
25,277
+25
+0.1% +$2.44K 1.38% 14
2022
Q1 		$2.56M Buy
25,252
+12,534
+99% +$1.32M 1.06% 20
2021
Q4 		$1.31M Buy
12,718
+6
+0% +$554 0.5% 31
2021
Q3 		$1.08M Buy
12,712
+164
+1% +$13.7K 0.44% 34
2021
Q2 		$1.05M Buy
12,548
+272
+2% +$22.3K 0.44% 35
2021
Q1 		$923K Buy
12,276
+5,856
+91% +$427K 0.41% 33
2020
Q4 		$438K Sell
6,420
-805
-11% -$52.4K 0.21% 83
2020
Q3 		$422K Sell
7,225
-601
-8% -$37.4K 0.22% 73
2020
Q2 		$508K Sell
7,826
-672
-8% -$42.3K 0.29% 53
2020
Q1 		$504K Buy
8,498
+63
+0.7% +$4.21K 0.24% 31
2019
Q4 		$627K Sell
8,435
-374
-4% -$26.3K 0.33% 57
2019
Q3 		$632K Buy
8,809
+1,137
+15% +$67.4K 0.36% 46
2019
Q2 		$418K Buy
7,672
+601
+8% +$32.4K 0.24% 79
2019
Q1 		$381K Buy
7,071
+405
+6% +$25K 0.23% 82
2018
Q4 		$437K Sell
6,666
-1,505
-18% -$112K 0.27% 38
2018
Q3 		$643K Buy
8,171
+112
+1% +$8.01K 0.39% 34
2018
Q2 		$519K Buy
8,059
+252
+3% +$16.6K 0.36% 32
2018
Q1 		$486K Buy
7,807
+738
+10% +$53K 0.33% 38
2017
Q4 		$513K Buy
+7,069
New +$514K 0.37% 32

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Copperwynd Financial's CVS Position: Q2 2025 in Review

Copperwynd Financial reduced its CVS Health (CVS) stake by 0.44% in Q2 2025, selling an estimated $3.61K and leaving 12,316 shares worth $850K. The position accounts for 0.21% of the portfolio, ranked #88.

Copperwynd Financial first reported a position in CVS in Q4 2017 and has held it in 31 quarters since. The position peaked at $2.56M in Q1 2022. 1,758 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Copperwynd Financial held 12,316 shares of CVS Health worth $850K as of Q2 2025.
  • Copperwynd Financial sold 55 CVS Health shares in Q2 2025, an estimated $3.61K.
  • CVS Health made up 0.21% of Copperwynd Financial's portfolio in Q2 2025, its #88 holding.
  • Copperwynd Financial first reported a position in CVS Health in Q4 2017 and has held it in 31 quarters since.
  • Copperwynd Financial's CVS Health position peaked at $2.56M in Q1 2022.
  • 1,758 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Copperwynd Financial's 13F filing for Q2 2025, filed 24 Jul 2025.